Follow
Mark Borris Aldonza
Mark Borris Aldonza
Seoul National University, Korea Advanced Institute of Science and Technology (KAIST)
Verified email at snu.ac.kr - Homepage
Title
Cited by
Cited by
Year
Stanniocalcin-2 (STC2): a potential lung cancer biomarker promotes lung cancer metastasis and progression
S Na, MB Aldonza, HJ Sung, YI Kim, YS Son, S Cho, JY Cho
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1854 (6), 668-676, 2015
592015
Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells
MBD Aldonza, YS Son, HJ Sung, JM Ahn, YJ Choi, YI Kim, S Cho, JY Cho
Oncotarget, 2017
392017
GC‐FID determination of cocaine and its metabolites in human bile and vitreous humor
P Fernández, M Aldonza, A Bouzas, M Lema, AM Bermejo, MJ Tabernero
Journal of Applied Toxicology: An International Journal 26 (3), 253-257, 2006
392006
Suppression of MAPK signaling and reversal of mTOR-dependent MDR1-associated multidrug resistance by 21α-methylmelianodiol in lung cancer cells
MBD Aldonza, JY Hong, SY Bae, J Song, WK Kim, J Oh, Y Shin, SH Lee, ...
PLoS One 10 (6), e0127841, 2015
382015
Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation
MBD Aldonza, JY Hong, SK Lee
Experimental and Molecular Medicine 49 (1), e286, 2017
362017
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
MBD Aldonza, J Ku, JY Hong, D Kim, SJ Yu, MS Lee, MC Prayogo, S Tan, ...
Science advances 6 (6), eaav7416, 2020
332020
Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation
MBD Aldonza, JY Hong, MV Alinsug, J Song, SK Lee
Oncotarget 7 (23), 34395-34419, 2016
322016
Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass
MBD Aldonza, RDD Reyes, YS Kim, J Ku, AM Barsallo, JY Hong, SK Lee, ...
Scientific Reports 11 (1), 8016, 2021
92021
Integrative mapping of the dog epigenome: Reference annotation for comparative intertissue and cross-species studies
KH Son, MBD Aldonza, AR Nam, KH Lee, JW Lee, KJ Shin, K Kang, ...
Science Advances 9 (27), eade3399, 2023
52023
Dual targeting of EGFR with PLK1 exerts therapeutic synergism in taxane-resistant lung adenocarcinoma by suppressing ABC transporters
SB Shin, DH Kim, DE Kim, MBD Aldonza, Y Kim, H Yim
Cancers 13 (17), 4413, 2021
52021
Multi-targeted therapy resistance via drug-induced secretome fucosylation
MBD Aldonza, J Cha, I Yong, J Ku, P Sinitcyn, D Lee, RE Cho, ...
Elife 12, e75191, 2023
12023
Secretome core fucosylation drives clonal drug resistance expansion and hypoxic control of metastasis
MBD Aldonza, KH Son, JY Cho
Cancer Research 84 (6_Supplement), 3265-3265, 2024
2024
Widespread multi-targeted therapy resistance via drug-induced secretome fucosylation
MBD Aldonza, J Cha, I Yong, J Ku, D Lee, P Sinitcyn, RE Cho, ...
bioRxiv, 2021
2021
Collateral resistance trajectories following failure to antimitotic drugs
MBD Aldonza
Cancer Research 79 (13_Supplement), 2118-2118, 2019
2019
Establishing Mitochondrial RNAs as Novel Functional Markers for Arthritis
KIM Sujin, KU Jayoung, MB ALDONZA, KIM Yoosik
한국생물공학회 학술대회, 175-175, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–15